Fundamental Data for STAA

Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.

# Employees: 408

Address: 1911 Walker Avenue,Monrovia,CA,USA

Phone: 626 303-7902

Fax: 626 303-2962

Website: www.staar.com

Email: info@STAAR.com

Sector: Medical

Industry: MED/DENTAL-SUPP

Executive Officers

Don Bailey (Chrmn.; Dir.)

Barry G. Caldwell (Presi.; C.E.O.; Dir.)

Deborah Andrews (C.F.O.; Prin. Acctg. Off.)

David Bailey (Presi. Int.opers.; Dir.)

David Morrison (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 3/15/2010

Mean EPS (Next Qtr): ($0.03)

Mean EPS (Year): ($0.16)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 3

Shares Performance

Period	STAA	Compare to S&P
YTD	55.88 %	29.00 %
4 Weeks	-3.89 %	-8.76 %
12 Weeks	10.75 %	3.13 %

Shares Information

Analyst Coverage: Y

Avg Volume: 47185

Shares Outstanding: 34M

Market Cap: $0.13B

52 Week High: $4.21

52 Week Low: $0.80

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 5/18/1992 STAA split by factor of 0.500

Earnings Performance

EPS Growth in Last Quarter: -25.00 %

EPS Growth in Last Year: 37.50 %

Sales Growth in Last Quarter: -5.25 %

Sales Growth in Last Quarter: 0.01 %

Financials

Qtr Book Value: $5.73

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: 1.750